H C Korting|R Lesch - JoVE Visualize

Showing results (191-200 of 328) with videos related to

Pageof 33

Sort By:

Skin Pharmacology and Physiology|December 21, 2004

Safety and efficacy of fluticasone propionate in the topical treatment of skin diseasesA Roeder, M Schaller, M Schäfer-Korting, et al.

Antimicrobial Agents and Chemotherapy|January 1, 1990

Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteersR Warlich, H C Korting, M Schäfer-Korting, et al.

International Journal of STD & AIDS|May 1, 1993

The suppressive effect of serum samples from patients with chancroid on human mononuclear cells correlates with the clinical picture and is interleukin-2-dependentH C Korting, R Zaba, R C Ballard, et al.

Journal of the American Academy of Dermatology|December 1, 1991

Topical liposome drugs to come: what the patent literature tells us. A reviewH C Korting, P Blecher, M Schäfer-Korting, et al.

European Journal of Clinical Pharmacology|October 1, 1982

Does cantharides blister fluid provide access to the peripheral compartment?M Schäfer-Korting, H C Korting, S Hiemstra, et al.

Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1996

0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effectsM J Kerscher, H C Korting, L Mehringer, et al.

The Journal of Infection|November 20, 1998

A model of human cutaneous candidosis based on reconstructed human epidermis for the light and electron microscopic study of pathogenesis and treatmentH C Korting, U Patzak, M Schaller, et al.

Mycoses|August 26, 1998

Shift from persistent oral pseudomembranous to erythematous candidosis in a human immunodeficiency virus (HIV)-infected patient upon combination treatment with an HIV protease inhibitorL Hoegl, E Thoma-Greber, M Röcken, et al.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 1981

[Amiodarone pigmentation. A rare, but typical drug side-effect]H C Korting, R Kolz, C Schmoeckel, et al.

European Journal of Clinical Pharmacology|January 1, 1990

Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgarisH C Korting, H Zienicke, M Schäfer-Korting, et al.

Pageof 33

Showing results (191-200 of 328) with videos related to

Sort By:

Pageof 33

Skin Pharmacology and Physiology|December 21, 2004

Safety and efficacy of fluticasone propionate in the topical treatment of skin diseasesA Roeder, M Schaller, M Schäfer-Korting, et al.

Antimicrobial Agents and Chemotherapy|January 1, 1990

Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteersR Warlich, H C Korting, M Schäfer-Korting, et al.

International Journal of STD & AIDS|May 1, 1993

The suppressive effect of serum samples from patients with chancroid on human mononuclear cells correlates with the clinical picture and is interleukin-2-dependentH C Korting, R Zaba, R C Ballard, et al.

Journal of the American Academy of Dermatology|December 1, 1991

Topical liposome drugs to come: what the patent literature tells us. A reviewH C Korting, P Blecher, M Schäfer-Korting, et al.

European Journal of Clinical Pharmacology|October 1, 1982

Does cantharides blister fluid provide access to the peripheral compartment?M Schäfer-Korting, H C Korting, S Hiemstra, et al.

Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1996

0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effectsM J Kerscher, H C Korting, L Mehringer, et al.

The Journal of Infection|November 20, 1998

A model of human cutaneous candidosis based on reconstructed human epidermis for the light and electron microscopic study of pathogenesis and treatmentH C Korting, U Patzak, M Schaller, et al.

Mycoses|August 26, 1998

Shift from persistent oral pseudomembranous to erythematous candidosis in a human immunodeficiency virus (HIV)-infected patient upon combination treatment with an HIV protease inhibitorL Hoegl, E Thoma-Greber, M Röcken, et al.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 1981

[Amiodarone pigmentation. A rare, but typical drug side-effect]H C Korting, R Kolz, C Schmoeckel, et al.

European Journal of Clinical Pharmacology|January 1, 1990

Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgarisH C Korting, H Zienicke, M Schäfer-Korting, et al.

Pageof 33